Gabriela Plesa

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Metastatic Breast Cancer

Top Venues

Cancer research communications

Science translational medicine

Science (New York, N.Y.)

Nature biomedical engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Payal Deepak Shah, Alexander C Huang, George X Xu, Robert J Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul J Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa E Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert A Anders, Tara C Mitchell
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer research communications 3 (5) (2023)
Payal Deepak Shah, Alexander C Huang, George X Xu, Robert J Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul J Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa E Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert A Anders, Tara C Mitchell
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer research communications 3 (5) (2023)
Payal Deepak Shah, Alexander C Huang, George X Xu, Robert J Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul J Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa E Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert A Anders, Tara C Mitchell
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer research communications 3 (5) (2023)
In-Young Jung, Robert L Bartoszek, Andrew J Rech, Sierra M Collins, Soon-Keat Ooi, Erik F Williams, Caitlin R Hopkins, Vivek Narayan, Naomi B Haas, Noelle V Frey, Elizabeth O Hexner, Donald L Siegel, Gabriela Plesa, David L Porter, Vito Adrian Cantu, John K Everett, Sonia Guedan, Shelley L Berger, Frederic D Bushman, Friederike Herbst, Joseph A Fraietta
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T cell-intrinsic Dysfunction. Cancer discovery (2023)
Payal Deepak Shah, Alexander C Huang, George X Xu, Robert J Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul J Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa E Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert A Anders, Tara C Mitchell
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer research communications 3 (5) (2023)
Payal Deepak Shah, Alexander C Huang, George X Xu, Robert J Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul J Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa E Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert A Anders, Tara C Mitchell
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer research communications 3 (5) (2023)
Saba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, Jai Patel, John Leferovich, Marilia Pinzone, Feng Shen, Katherine D Cummins, Gabriela Plesa, Vito Adrian Cantu, Shantan Reddy, Frederic D Bushman, Saar I Gill, Una O'Doherty, Roderick O'Connor, Michael C Milone
Rapid manufacturing of non-activated potent CAR T cells. Nature biomedical engineering 6 (2) (2022)
Alfred L Garfall, Adam David Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Donald L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood cancer discovery (2022)
In-Young Jung, Vivek Narayan, Sierra M Collins, Andrew J Rech, Robert Bartoszek, Gwanui Hong, Megan M Davis, Jun Xu, Alina C Boesteanu, Julie S Barber-Rotenberg, Gabriela Plesa, Simon F Lacey, Julie K Jadlowsky, Donald L Siegel, Dana M Hammill, Park F Cho-Park, Shelley L Berger, Naomi B Haas, Joseph A Fraietta
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion. Science translational medicine 14 (670) (2022)
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam David Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa E Gonzalez, Jun Xu, In-Young Jung, J Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-Mckee, Andrew D Fesnak, Donald L Siegel, Bruce L Levine, Julie K Jadlowsky, Regina M Young, Anne Chew, Wei-Ting Hwang, Elizabeth O Hexner, Beatriz M Carreno, Christopher L Nobles, Frederic D Bushman, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Howard Y Chang, Yangbing Zhao, Simon F Lacey, Carl H June
CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) 367 (6481) (2020)
Donald M O'Rourke, Mac Lean P Nasrallah, Arati S Desai, Jan Joseph Melenhorst, Keith G Mansfield, Jennifer J D Morrissette, Maria Martinez-Lage, Steven Brem, Eileen Maloney, Angela Shen, Randi Isaacs, Suyash Mohan, Gabriela Plesa, Simon F Lacey, Jean-Marc Navenot, Zhaohui Zheng, Bruce L Levine, Hideho Okada, Carl H June, Jennifer L Brogdon, Marcela V Maus
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science translational medicine 9 (399) (2018)